A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer

por Steele, N, Anthony, A, Saunders, M, Esmarck, B, Ehrnrooth, E, Kristjansen, P E G, Nihlén, A, Hansen, L T, Cassidy, J
Publicado 2012

Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer

por Koukourakis, M I, Giatromanolaki, A, Tsakmaki, V, Danielidis, V, Sivridis, E
Publicado 2012

Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules

por Shimokawa, T, Seike, M, Soeno, C, Uesaka, H, Miyanaga, A, Mizutani, H, Kitamura, K, Minegishi, Y, Noro, R, Okano, T, Yoshimura, A, Gemma, A
Publicado 2012

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

por Scartozzi, M, Giampieri, R, Maccaroni, E, Del Prete, M, Faloppi, L, Bianconi, M, Galizia, E, Loretelli, C, Belvederesi, L, Bittoni, A, Cascinu, S
Publicado 2012

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

por Kwon, M J, Park, S, Choi, J Y, Oh, E, Kim, Y J, Park, Y-H, Cho, E Y, Kwon, M J, Nam, S J, Im, Y-H, Shin, Y K, Choi, Y-L
Publicado 2012

Impact of genomic stability on protein expression in endometrioid endometrial cancer

por Lomnytska, M I, Becker, S, Gemoll, T, Lundgren, C, Habermann, J, Olsson, A, Bodin, I, Engström, U, Hellman, U, Hellman, K, Hellström, A-C, Andersson, S, Mints, M, Auer, G
Publicado 2012

Increased risk of laryngeal and pharyngeal cancer after gastrectomy for ulcer disease in a population-based cohort study

por Lagergren, J, Lindam, A
Publicado 2012

Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes

por Loyo, M, Schussel, J, Colantuoni, E, Califano, J, Brait, M, Kang, S, Koch, W M, Sidransky, D, Westra, W H, Taube, J M
Publicado 2012

Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study

por Zhang, X, Giovannucci, E L, Wu, K, Smith-Warner, S A, Fuchs, C S, Pollak, M, Willett, W C, Ma, J
Publicado 2012

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

por Mochizuki, I, Takiuchi, H, Ikejiri, K, Nakamoto, Y, Kinugasa, Y, Takagane, A, Endo, T, Shinozaki, H, Takii, Y, Takahashi, Y, Mochizuki, H, Kotake, K, Kameoka, S, Takahashi, K, Watanabe, T, Watanabe, M, Boku, N, Tomita, N, Matsubara, Y, Sugihara, K
Publicado 2012

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women

por Sidon, L, Ingham, S, Clancy, T, Clayton, R, Clarke, A, Jones, E A, Lalloo, F, Evans, D G R
Publicado 2012

Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells

por Tanizaki, J, Okamoto, I, Takezawa, K, Sakai, K, Azuma, K, Kuwata, K, Yamaguchi, H, Hatashita, E, Nishio, K, Janne, P A, Nakagawa, K
Publicado 2012

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma

por Konishi, H, Ichikawa, D, Komatsu, S, Shiozaki, A, Tsujiura, M, Takeshita, H, Morimura, R, Nagata, H, Arita, T, Kawaguchi, T, Hirashima, S, Fujiwara, H, Okamoto, K, Otsuji, E
Publicado 2012

Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma

por Cella, D, Bushmakin, A G, Cappelleri, J C, Charbonneau, C, Michaelson, M D, Motzer, R J
Publicado 2012

Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients

por Doi, T, Takiuchi, H, Ohtsu, A, Fuse, N, Goto, M, Yoshida, M, Dote, N, Kuze, Y, Jinno, F, Fujimoto, M, Takubo, T, Nakayama, N, Tsutsumi, R
Publicado 2012

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2

por Brain, E, Isambert, N, Dalenc, F, Diéras, V, Bonneterre, J, Rezai, K, Jimenez, M, Mefti-Lacheraf, F, Cottura, E, Tresca, P, Vanlemmens, L, Mahier-Aït Oukhatar, C, Lokiec, F, Fumoleau, P
Publicado 2012

Serum biomarker panels for the diagnosis of gastric adenocarcinoma

por Ahn, H S, Shin, Y S, Park, P J, Kang, K N, Kim, Y, Lee, H-J, Yang, H-K, Kim, C W
Publicado 2012

FGFR2 gene amplification and clinicopathological features in gastric cancer

por Matsumoto, K, Arao, T, Hamaguchi, T, Shimada, Y, Kato, K, Oda, I, Taniguchi, H, Koizumi, F, Yanagihara, K, Sasaki, H, Nishio, K, Yamada, Y
Publicado 2012

The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells

por Nyhan, M J, O'Donovan, T R, Elzinga, B, Crowley, L C, O'Sullivan, G C, McKenna, S L
Publicado 2012

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group

por du Bois, A, Vergote, I, Wimberger, P, Ray-Coquard, I, Harter, P, Curtis, L B, Mitrica, I
Publicado 2012